Platform Bundling Threatens Claim Specialists

This is a distribution risk, not just a product risk. Patent teams often buy software the same way they buy outside counsel panels, they want fewer approved vendors, fewer security reviews, and fewer tools to train on. If Patlytics or Clarivate can cover search, drafting, invalidity, monitoring, and basic claim charts in one system, a specialist can lose the seat even when its charts are better.

• Patlytics is explicitly positioning as a single patent workflow platform, spanning invention disclosure, drafting, infringement detection, invalidity analysis, and automated claim charts. That matters because claim charting becomes one feature inside a larger budget line, not a separate purchase decision.
  2 patlytics 5 patlytics
• Incumbents have the same bundling advantage from the other direction. Clarivate bought Rowan Patents in July 2024 to extend from IP management and intelligence into drafting and prosecution, while Questel has spread Sophia across search, document review, and query workflows on top of its existing patent data stack.
  3 clarivate 4 questel
• This pattern already shows up elsewhere in legal software. Firms increasingly mix broad platforms and point tools, but seat allocation follows the workflow that is used every day. A specialist wins only if its output is so much better that teams tolerate another contract, another review, and another place to work.
  1 sacra 6 sacra

The next phase of competition is likely to be decided by who owns the full patent workbench. Broader vendors will keep making claim charts good enough and cheaper to buy as part of a suite. That pushes specialists to prove they drive materially better case outcomes, not just faster chart generation.